Target intelligence / Profile preview

Karyocyte

Molecular classification
Other
01

Overview

Karyocyte is a general biological term used to describe any nucleated cell, most commonly applied in hematology and clinical pathology to distinguish these cells from anucleated erythrocytes and platelets [1], [16]. In medical literature and therapeutic research, the term often serves as a collective designation for bone marrow precursor cells and circulating leukocytes, including monocytes, neutrophils, and lymphocytes [1], [8]. While not a single molecular target like a receptor or enzyme, karyocytes represent a critical cellular population targeted by growth factors such as erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) to regulate cell production and differentiation [12], [18]. Recent studies have highlighted the role of 'circulating karyocytes' as active drivers of chronic inflammatory diseases like atherosclerosis, where their activation and gene expression profiles are targeted to reduce systemic inflammation [1]. Additionally, the presence or count of specific karyocytes, such as nucleated red blood cells, serves as a vital biomarker for physiological stress, marrow dysfunction, and various hematological malignancies [10].

Other names
Nucleated cellNucleated blood cellNormoblastErythroblastCirculating karyocyte
02

Mechanism of action

Modulation of hematopoietic cell proliferation, differentiation, and gene expression; activation of specific cell-surface receptors (e.g., EPOR, G-CSFR, TPOR) to stimulate lineage-specific development.

03

Biological functions

HematopoiesisImmune responseInflammationHemostasisOxygen transport
04

Disease associations

LeukemiaAnemiaAtherosclerosisMyelodysplastic syndromeInflammatory disease
05

Safety considerations

MyelosuppressionCytokine release syndromeLeukocytosisThrombosis
06

Interacting drugs

Erythropoietin

5 more in the full profile.

07

Biomarkers

Nucleated Red Blood Cell (NRBC) countAbsolute Neutrophil Count (ANC)CD34 expressionCD45 expression

Beyond the preview

Go deeper on Karyocyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Karyocyte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call